Effect of intranasal esketamine on cognitive functioning in healthy participants: a randomized, double-blind, placebo-controlled study
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of intranasal esketamine on cognitive functioning in healthy participants: a randomized, double-blind, placebo-controlled study
Authors
Keywords
Cognitive functioning, Cogstate<sup>®</sup> computerized test battery, Intranasal esketamine, Treatment-resistant depression
Journal
PSYCHOPHARMACOLOGY
Volume 235, Issue 4, Pages 1107-1119
Publisher
Springer Nature
Online
2018-02-01
DOI
10.1007/s00213-018-4828-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study
- (2016) Jaskaran B. Singh et al. BIOLOGICAL PSYCHIATRY
- Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
- (2016) Ronald S Duman et al. NATURE MEDICINE
- Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression
- (2015) D. Jeffrey Newport et al. AMERICAN JOURNAL OF PSYCHIATRY
- Mirtazapine as positive control drug in studies examining the effects of antidepressants on driving ability
- (2015) Joris C. Verster et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Intranasal Drug Delivery in Neuropsychiatry: Focus on Intranasal Ketamine for Refractory Depression
- (2015) Chittaranjan Andrade JOURNAL OF CLINICAL PSYCHIATRY
- R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
- (2015) C Yang et al. Translational Psychiatry
- Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression
- (2014) Paulo R. Shiroma et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults
- (2014) Roger S. McIntyre et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Ketamine infusions for treatment resistant depression: a series of 28 patients treated weekly or twice weekly in an ECT clinic
- (2014) Peter R Diamond et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Neurocognitive Effects of Ketamine and Association with Antidepressant Response in Individuals with Treatment-Resistant Depression: A Randomized Controlled Trial
- (2014) James W Murrough et al. NEUROPSYCHOPHARMACOLOGY
- Synaptic Mechanisms Underlying Rapid Antidepressant Action of Ketamine
- (2013) Ege T. Kavalali et al. AMERICAN JOURNAL OF PSYCHIATRY
- Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
- (2013) James W. Murrough et al. AMERICAN JOURNAL OF PSYCHIATRY
- Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response
- (2013) James W. Murrough et al. PSYCHOPHARMACOLOGY
- Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression
- (2012) James W. Murrough et al. BIOLOGICAL PSYCHIATRY
- Decreased Serum Levels of Mature Brain-Derived Neurotrophic Factor (BDNF), but Not Its Precursor proBDNF, in Patients with Major Depressive Disorder
- (2012) Taisuke Yoshida et al. PLoS One
- Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study
- (2009) Celia J. A. Morgan et al. ADDICTION
- Validity of the CogState Brief Battery: Relationship to Standardized Tests and Sensitivity to Cognitive Impairment in Mild Traumatic Brain Injury, Schizophrenia, and AIDS Dementia Complex
- (2009) P. Maruff et al. ARCHIVES OF CLINICAL NEUROPSYCHOLOGY
- Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
- (2009) Marije aan het Rot et al. BIOLOGICAL PSYCHIATRY
- Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial
- (2009) Sanjay J. Mathew et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- A comparison of the CogState Schizophrenia Battery and the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Battery in assessing cognitive impairment in chronic schizophrenia
- (2009) Robert H. Pietrzak et al. JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY
- Ketamine and the next generation of antidepressants with a rapid onset of action
- (2009) Rodrigo Machado-Vieira et al. PHARMACOLOGY & THERAPEUTICS
- Ketamine use, cognition and psychological wellbeing: a comparison of frequent, infrequent and ex-users with polydrug and non-using controls
- (2008) Celia J. A. Morgan et al. ADDICTION
- Quetiapine augmentation in depressed patients with partial response to antidepressants
- (2008) James S Olver et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now